Company profile for Brexogen

PharmaCompass

Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

Update your Virtual Booth on PharmaCompass, ask us

About

Developer of cell therapy designed to target incurable diseases via stem cell exosome. The company develops optimized parental cells for exosome production with superior proliferation and exosome secretion ability than stem cells, enabling physicians to provide a solution for mass production and a prerequisite for the commercialization of exosomes.

List your booth number for exhibitions, ask us

CONTACT DETAILS

Click the arrow to open the dropdown
Country
Country
South Korea
Address
Address
9F, 9, Beobwon-ro 8-gil, Songpa-gu, Seoul, 05855, Republic of Korea
Telephone
Telephone
+82-2-430-0401
Linkedin
Linkedin
youtube
YouTube
Twitter
Twitter

Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

Events

Webinars & Exhibitions

Default Event

DDL Conference

Not Confirmed

envelop Contact Supplier

DDL Conference

Post an Enquiry

Meeting

Digital content

Create Content with PharmaCompass, ask us

NEWS #PharmaBuzz

read-more
read-more

https://www.prnewswire.com/news-releases/brexogen-and-bmi-korea-enter-strategic-technology-transfer-agreement-for-exosome-therapeutics-302378710.html

PR NEWSWIRE
19 Feb 2025

ABOUT THIS PAGE

Ask Us for Pharmaceutical Supplier and Partner
Ask Us, Find A Supplier / Partner
No Commissions, No Strings Attached, Get Connected for FREE

What are you looking for?

How can we help you?

The request can't be empty

Please read our Privacy Policy carefully

You must agree to the privacy policy

The name can't be empty
The company can't be empty.
The email can't be empty Please enter a valid email.
The mobile can't be empty